GW649868

From Wikipedia, the free encyclopedia

GW649868 is the tentative name for a drug in development by GSK. Currently in late-pre-clinical stage, this drug for sleep disorders is the only orexin antagonist currently in development.

GSK presentation

Pills  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../g/w/6/GW649868_3cfb.html"